PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 28-38

  Liu, Shuang ^a,b,c   Lai, Li ^a,b   Zuo, Qiuhong ^a,b   Dai, Fujun ^a,b   Wu, Lin ^a,b   Wang, Yan ^a,b   Zhou, Qingxia ^a,b   Liu, Jian ^d   Liu, Jiang ^e   Li, Lei ^a,b   Lin, Qingxiang ^a,b   Creighton, Chad J ^d   Costello, Myra Grace ^d   Huang, Shixia ^d   Jia, Caifeng ^a,b   Liao, Lujian ^a,b   Luo, Honglin ^f   Fu, Junjiang ^g   Liu, Mingyao ^a,b   Yi, Zhengfang ^a,b   Xiao, Jianru ^h   Li, Xiaotao ^a,d,h   more..

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b B326 Science Building   (China)

^c GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e HANGZHOU NORMAL UNIVERSITY   (China)

^f ST PAUL S HOSPITAL   (Canada)

^g SOUTHWEST MEDICAL UNIVERSITY   (China)

^h SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; E Selectin; FoxO1; PKAca; REG ; VCAM 1

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PROTEASOME; PROTEIN KINASE A CATALYTIC SUBUNIT ALPHA; REGGAMMA PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; AUTOANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; FOXO1 PROTEIN, MOUSE; KI ANTIGEN; PROTEIN KINASE A CALPHA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; ANIMAL EMBRYO; CELL MOTION; CORNEA; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRIMARY CELL CULTURE; VASCULARIZATION;

ANIMALS; AORTA; AUTOANTIGENS; CELL MOVEMENT; CORNEA; CYCLIC AMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNITS; E-SELECTIN; EMBRYO, MAMMALIAN; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PRIMARY CELL CULTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901239764     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.02.007     Document Type: Article

References (59)

1. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3:65-71.
3. Costa C., Soares R., Schmitt F. Angiogenesis: now and then. APMIS 2004, 112:402-412.
4. Roodhart J.M., Langenberg M.H., Witteveen E., Voest E.E. The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway. Curr Clin Pharmacol 2008, 3:132-143.
5. Koch A.E., Halloran M.M., Haskell C.J., Shah M.R., Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519.
6. Kim W., Moon S.O., Lee S., Sung M.J., Kim S.H., Park S.K. Adrenomedullin reduces VEGF-induced endothelial adhesion molecules and adhesiveness through a phosphatidylinositol 3'-kinase pathway. Arterioscler Thromb Vasc Biol 2003, 23:1377-1383.
7. Schweighofer B., Testori J., Sturtzel C., Sattler S., Mayer H., Wagner O., et al. The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 2009, 102:544-554.
8. Koch A.E., Turkiewicz W., Harlow L.A., Pope R.M. Soluble E-selectin in arthritis. Clin Immunol Immunopathol 1993, 69:29-35.
9. Hebbar M., Peyrat J.P. Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int J Biol Markers 2000, 15:15-21.
10. Byrne G.J., Ghellal A., Iddon J., Blann A.D., Venizelos V., Kumar S., et al. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst 2000, 92:1329-1336.
11. Ferdous A., Morris J., Abedin M.J., Collins S., Richardson J.A., Hill J.A. Forkhead factor FoxO1 is essential for placental morphogenesis in the developing embryo. Proc Natl Acad Sci U S A 2011, 108:16307-16312.
12. van der Horst A., Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007, 8:440-450.
13. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
14. Kops G.J., Burgering B.M. Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med (Berl) 1999, 77:656-665.
15. Van Der Heide L.P., Hoekman M.F., Smidt M.P. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004, 380:297-309.
16. Lee J.W., Chen H., Pullikotil P., Quon M.J. Protein kinase A-alpha directly phosphorylates FoxO1 in vascular endothelial cells to regulate expression of vascular cellular adhesion molecule-1 mRNA. J Biol Chem 2011, 286:6423-6432.
17. Yang J., Shi Q.D., Song T.B., Feng G.F., Zang W.J., Zong C.H., et al. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro. Peptides 2013, 42C:105-111.
18. Namkoong S., Kim C.K., Cho Y.L., Kim J.H., Lee H., Ha K.S., et al. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell Signal 2009, 21:906-915.
19. Lu Y., Xiong Y., Huo Y., Han J., Yang X., Zhang R., et al. Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway. Proc Natl Acad Sci U S A 2011, 108:2957-2962.
20. Venkatesh P.K., Pattillo C.B., Branch B., Hood J., Thoma S., Illum S., et al. Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc Res 2010, 85:661-670.
21. D'Angelo G., Lee H., Weiner R.I. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997, 67:353-366.
22. Kim S.H., Cho Y.R., Kim H.J., Oh J.S., Ahn E.K., Ko H.J., et al. Antagonism of VEGF-A-induced increase in vascular permeability by an integrin alpha3beta1-Shp-1-cAMP/PKA pathway. Blood 2012, 120:4892-4902.
23. Jin H., Garmy-Susini B., Avraamides C.J., Stoletov K., Klemke R.L., Varner J.A. A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting. Blood 2010, 116:5773-5783.
24. Menon J., Doebele R.C., Gomes S., Bevilacqua E., Reindl K.M., Rosner M.R. A novel interplay between Rap1 and PKA regulates induction of angiogenesis in prostate cancer. PLoS One 2012, 7:e49893.
25. Kim S., Bakre M., Yin H., Varner J.A. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J Clin Invest 2002, 110:933-941.
26. Clegg C.H., Correll L.A., Cadd G.G., McKnight G.S. Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit. J Biol Chem 1987, 262:13111-13119.
27. Laudanna C., Campbell J.J., Butcher E.C. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J Biol Chem 1997, 272:24141-24144.
28. Rahimi N. The ubiquitin-proteasome system meets angiogenesis. Mol Cancer Ther 2012, 11:538-548.
29. Li X., Amazit L., Long W., Lonard D.M., Monaco J.J., O'Malley B.W. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007, 26:831-842.
30. Li X., Lonard D.M., Jung S.Y., Malovannaya A., Feng Q., Qin J., et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124:381-392.
31. Li L., Zhao D., Wei H., Yao L., Dang Y., Amjad A., et al. REGgamma deficiency promotes premature aging via the casein kinase 1 pathway. Proc Natl Acad Sci U S A 2013, 110:11005-11010.
32. Dong S., Jia C., Zhang S., Fan G., Li Y., Shan P., et al. The REGgamma proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab 2013, 18:380-391.
33. Barton L.F., Runnels H.A., Schell T.D., Cho Y., Gibbons R., Tevethia S.S., et al. Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol 2004, 172:3948-3954.
34. Murata S., Kawahara H., Tohma S., Yamamoto K., Kasahara M., Nabeshima Y., et al. Growth retardation in mice lacking the proteasome activator PA28gamma. J Biol Chem 1999, 274:38211-38215.
35. Roessler M., Rollinger W., Mantovani-Endl L., Hagmann M.L., Palme S., Berndt P., et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006, 5:2092-2101.
36. Liu J., Yu G., Zhao Y., Zhao D., Wang Y., Wang L., et al. REGgamma modulates p53 activity by regulating its cellular localization. J Cell Sci 2010, 123:4076-4084.
37. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29:15-18.
38. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011, 17:1359-1370.
39. Matsuo Y., Sawai H., Ochi N., Yasuda A., Sakamoto M., Takahashi H., et al. Proteasome inhibitor MG132 inhibits angiogenesis in pancreatic cancer by blocking NF-kappaB activity. Dig Dis Sci 2010, 55:1167-1176.
40. Nawrocki S.T., Bruns C.J., Harbison M.T., Bold R.J., Gotsch B.S., Abbruzzese J.L., et al. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 2002, 1:1243-1253.
41. Chen X., Barton L.F., Chi Y., Clurman B.E., Roberts J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007, 26:843-852.
42. Baker M., Robinson S.D., Lechertier T., Barber P.R., Tavora B., D'Amico G., et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 2012, 7:89-104.
43. Connor K.M., Krah N.M., Dennison R.J., Aderman C.M., Chen J., Guerin K.I., et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 2009, 4:1565-1573.
44. Lai L., Liu J., Zhai D., Lin Q., He L., Dong Y., et al. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2. Br J Pharmacol 2012, 165:1084-1096.
45. Ruzinova M.B., Schoer R.A., Gerald W., Egan J.E., Pandolfi P.P., Rafii S., et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003, 4:277-289.
46. Ghersa P., Hooft van Huijsduijnen R., Whelan J., Cambet Y., Pescini R., DeLamarter J.F. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994, 269:29129-29137.
47. Abid M.R., Shih S.C., Otu H.H., Spokes K.C., Okada Y., Curiel D.T., et al. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J Biol Chem 2006, 281:35544-35553.
48. Abid M.R., Nadeau R.J., Spokes K.C., Minami T., Li D., Shih S.C., et al. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28:2042-2048.
49. Stannard A.K., Khurana R., Evans I.M., Sofra V., Holmes D.I., Zachary I. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2007, 27:494-502.
50. Dong A., Shen J., Zeng M., Campochiaro P.A. Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. Proc Natl Acad Sci U S A 2011, 108:14614-14619.
51. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.S., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 2007, 110:3891-3899.
52. Fukushi J., Ono M., Morikawa W., Iwamoto Y., Kuwano M. The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J Immunol 2000, 165:2818-2823.
53. Chen H., Lin A.S., Li Y., Reiter C.E., Ver M.R., Quon M.J. Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion. J Biol Chem 2008, 283:29228-29238.
54. Furuyama T., Kitayama K., Shimoda Y., Ogawa M., Sone K., Yoshida-Araki K., et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 2004, 279:34741-34749.
55. van Wetering S., van den Berk N., van Buul J.D., Mul F.P., Lommerse I., Mous R., et al. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol 2003, 285:C343-C352.
56. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993, 91:2235-2243.
57. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-848.
58. Hattori Y., Yamamoto S., Matsuda N. Sympathetic control of VEGF angiogenic signaling: dual regulations by alpha 2-adrenoceptor activation?. Circ Res 2007, 101:642-644.
59. Shaik S., Nucera C., Inuzuka H., Gao D., Garnaas M., Frechette G., et al. SCF(beta-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J Exp Med 2012, 209:1289-1307.